Approval · Notice of Compliance 36151 · 2025
PYLERA: Notice of Compliance 36151
Issued October 10, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36151
- Date
- October 10, 2025
- Company
- Laboratoires Juvise PharmaceuticalsVilleurbanne, --, France
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production. Change in the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PYLERA | Not yet assigned | — |
Medicinal ingredients
- CHLORTETRACYCLINE HYDROCHLORIDE 125 MG per CAP
- METRONIDAZOLE 125 MG per CAP
- BISMUTH SUBCITRATE POTASSIUM 40 MG per CAP